Form D · Biotechnology
Ceptur Therapeutics, Inc.
Hillsborough, NJ · CIK 0001810375
Offering snapshot reported Mar 9, 2022 · SEC filing
- Reported sold
- $21.5M Offering amount: $75M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2022 | Initial | $21,499,994 | No comparison | 9 | SEC filing |
| Aug 14, 2020 | Initial | $6,200,000 | No comparison | 11 | SEC filing |
| May 4, 2020 | Initial | $75,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436411
Source: Form D, filed Mar 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| D. James Ballance | Director |
| Cynthia Davis | Executive |
| Paiman Peter Ghoroghchian | Director, Executive |
| Rafal Goraczniak | Director |
| Samuel I. Gunderson | Director |
| Daniel Heller | Director |
| Aaron Kantoff | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Ilene Court, Bldg. 8, Unit 9
Hillsborough, NJ, 08844
Hillsborough, NJ, 08844